Cite
HARVARD Citation
Hughes, D. et al. (2017). Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study. Journal of medical genetics. 54 (4), pp. 288-296. [Online].